Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by desolationsoundon Nov 06, 2014 10:06pm

195 Views

Post# 23104996

RE:RE:awfully quiet

Hi rjc7
The other " deadline" is Nov 26th when they have the Ontaro Chamber of Commerce Awards.
Making annoucements in December with all the other distractions going on is a wee bit
too late .... Any announcement of just the prototype being successfully built will drive up the SP past $ 1 I think
- DS

Bullboard Posts

Eminent acquires promising Nevada gold project